A empresa de dispositivos médicos Globus Medical relatou um aumento de 115,9% na receita trimestral para US $ 629,69 milhões, superando as expectativas dos analistas. Medical device company Globus Medical reported a 115.9% YoY increase in quarterly revenue to $629.69m, surpassing analyst expectations.

A empresa de dispositivos médicos Globus Medical recebeu cobertura positiva de analistas de pesquisa, incluindo BTIG Research, Barclays, Truist Financial, Stifel Nicolaus e Morgan Stanley. Medical device company Globus Medical received positive coverage from research analysts, including BTIG Research, Barclays, Truist Financial, Stifel Nicolaus, and Morgan Stanley. Esses analistas aumentaram suas metas de preço para a empresa, com classificações médias para as ações da Moderate Buy. These analysts increased their price targets for the company, with average ratings for the stock at Moderate Buy. A Globus Medical relatou um aumento de 115,9% na receita trimestral para US $ 629,69 milhões, superando as expectativas dos analistas de US $ 615,33 milhões. Globus Medical reported a 115.9% YoY increase in quarterly revenue to $629.69m, surpassing analyst expectations of $615.33m. Investidores institucionais e fundos de hedge possuem 95,16% das ações da empresa. Institutional investors and hedge funds own 95.16% of the company's stock.